The drugmaker reported adjusted earnings per share of 92 cents, beating expectations of 67 cents, according to analysts polled by FactSet.

Pfizer CEO Albert Bourla on Tuesday said uncertainty around President Donald Trump's planned pharmaceutical tariffs is ...

The company’s CEO said he’s had “productive discussions” with Trump administration officials on a recently launched trade ...

A number of US pharmaceutical groups have recently made announcements about expanding domestic manufacturing. These include ...

Drugmaker executives have projected confidence they can mitigate the impact of any levies Trump imposes on the industry. Yet ...

Pfizer CEO Albert Bourla said the pharmaceutical ... the company behind fast food chains like Taco Bell and Pizza Hut, expects little impact from tariffs on its supply chain, CFO Chris Turner ...

Like his Big Pharma peers, Pfizer (PFE ... said the company is already expecting a $150 million impact in 2025 from the current slate of tariffs but did not detail which products are impacted.

President Trump and British Prime Minister Keir Starmer announced a new trade agreement. Other countries, including China, ...

Pfizer said on Tuesday it would generate $1.7 billion more in savings from cost cuts to its manufacturing and research ...

Pfizer CEO Albert Bourla on Tuesday said ... the guidance “does not currently include any potential impact related to future tariffs and trade policy changes, which we are unable to predict ...